Sarcoptic Mange In Dogs: Comprehensive Veterinary Reference Guide

Sarcoptic mange, also known as canine scabies, is a highly contagious and intensely pruritic (itchy) skin disease of dogs caused by the microscopic mite Sarcoptes scabiei var. canis. This condition is a common differential diagnosis for any dog presenting with severe itching, hair loss, and crusting skin lesions. While treatable, the intense discomfort it causes can significantly impair a dog's quality of life, and its zoonotic potential means it can temporarily affect human family members. This comprehensive veterinary reference guide provides an exhaustive overview of sarcoptic mange in dogs, covering its etiology, clinical presentation, diagnostic methods, treatment protocols, prevention strategies, and regional considerations for pet owners and veterinary professionals across the United States, Canada, Europe, and Australia.

Quick Q&A

Question: Can humans catch sarcoptic mange from dogs? Answer: Yes, Sarcoptes scabiei var. canis is zoonotic and can temporarily infest humans. This causes a short-lived, intensely itchy rash, typically on the arms, trunk, and abdomen. However, the mites cannot complete their life cycle on human skin, so the infestation is self-limiting and resolves once the dog is treated.

Introduction to Sarcoptic Mange

Sarcoptic mange is one of the most common and frustrating skin conditions encountered in small animal practice. The disease is caused by infestation with the burrowing mite Sarcoptes scabiei var. canis. This mite is an obligate parasite, meaning it must live on a host to survive. The entire life cycle of the mite, from egg to adult, takes place on the dog's skin, typically lasting 17 to 21 days. Female mites burrow into the stratum corneum (the outermost layer of the skin) to lay eggs, which triggers a severe allergic and inflammatory response in the host. This response, rather than the mites themselves, is responsible for the intense pruritus (itching) that is the hallmark of the disease.

The condition is not seasonally restricted and can occur in dogs of any age, breed, or sex. However, it is more commonly seen in young dogs, dogs with compromised immune systems, or those living in crowded or unsanitary conditions, such as shelters or breeding kennels. The global distribution of Sarcoptes scabiei means that sarcoptic mange is a concern for veterinarians and pet owners worldwide, from urban centers in the United States and Canada to rural areas in Europe and Australia.

Etiology and Life Cycle of Sarcoptes scabiei var. canis

Understanding the life cycle of the mite is crucial for effective treatment and prevention. The Sarcoptes scabiei mite is a small, round arachnid, barely visible to the naked eye (approximately 0.2 to 0.4 mm in length). The female mite is slightly larger than the male. The life cycle consists of four stages: egg, larva, nymph, and adult.

The Burrowing Female and Egg Deposition

The life cycle begins when a fertilized adult female mite burrows into the dog's epidermis, creating a characteristic serpentine burrow or tunnel. Within this burrow, she lays 2 to 3 eggs per day over her lifetime, which can last 3 to 4 weeks. The eggs are oval and approximately 0.1 mm in length.

Larval and Nymphal Stages

After 3 to 5 days, the eggs hatch into six-legged larvae. These larvae are highly mobile and often emerge from the burrow to the skin surface. They then molt into eight-legged nymphs. The nymphs undergo further molting to become adults. The entire development from egg to adult mite takes approximately 10 to 14 days under optimal conditions (around 30 degrees Celsius and high humidity). Adult mites mate on the skin surface, after which the male dies, and the female burrows to begin a new cycle.

Off-Host Survival

A key factor in the transmission and persistence of sarcoptic mange is the mite's ability to survive off the host for a limited time. While they are obligate parasites, Sarcoptes scabiei mites can survive for 2 to 6 days in a cool, humid environment away from the host. This means that contaminated bedding, grooming tools, collars, and even the environment (e.g., carpets, kennels) can serve as fomites for transmission.

Transmission and Epidemiology

Sarcoptic mange is highly contagious. The primary mode of transmission is direct contact between an infested dog and a susceptible dog. This can occur during play, grooming, or simply sharing a living space. The mites are not host-specific in a strict sense; while Sarcoptes scabiei var. canis is the variant adapted to dogs, it can also infest other animals, including foxes, cats, and humans.

Regional Prevalence and Risk Factors

• United States and Canada: Sarcoptic mange is a common diagnosis in many parts of North America. It is particularly prevalent in areas with large populations of stray dogs or wildlife reservoirs, such as foxes and coyotes. According to the American Veterinary Medical Association (AVMA), dogs that frequent dog parks, boarding facilities, or grooming salons are at increased risk. The Canadian Veterinary Medical Association (CVMA) notes that outbreaks can occur in northern communities where dogs are housed in close quarters.
• Europe: In Europe, the European Food Safety Authority (EFSA) and the Federation of Veterinarians of Europe (FVE) recognize sarcoptic mange as a significant welfare concern, especially in kennel environments and among hunting dogs that may contact foxes. The disease is reportable in some European countries.
• Australia: In Australia, the Department of Agriculture, Fisheries and Forestry (DAFF) and the Australian Veterinary Association (AVA) highlight that sarcoptic mange is endemic in wild foxes, which act as a major reservoir for the disease. This poses a constant risk to domestic dogs, particularly those in rural or semi-rural areas.

Zoonotic Potential (Human Scabies)

A critical concern for pet owners is the zoonotic nature of the mite. When a dog with sarcoptic mange comes into close contact with a human, the mites can transfer to the human skin. This causes a condition known as "pseudoscabies" or "animal-transmitted scabies." In humans, the mites cause an intensely itchy rash, often on the arms, trunk, and waistline. However, because Sarcoptes scabiei var. canis is not adapted to humans, the mites cannot complete their life cycle or reproduce on human skin. The infestation is self-limiting, and the itching typically resolves within a few days to weeks after the dog has been successfully treated. Nevertheless, the symptoms can be distressing, and it is important for owners to be aware of this risk. The Centers for Disease Control and Prevention (CDC) in the United States advises that people with symptoms should consult their physician for symptomatic relief, such as topical corticosteroids or antihistamines.

Clinical Signs and Symptoms

The clinical presentation of sarcoptic mange is characterized by an intense, often debilitating pruritus. The itching is typically the first and most severe sign, often appearing before any visible skin lesions.

The Pruritic Cascade

The itching is caused by a Type I (immediate) and Type IV (delayed) hypersensitivity reaction to the mite's saliva, feces, eggs, and other body parts. This allergic response is so severe that dogs will often scratch, bite, and rub themselves relentlessly, sometimes to the point of self-mutilation. The pruritus is often exacerbated by warmth, such as when the dog lies near a heater or under a blanket.

Common Lesion Locations

The distribution of lesions is a key diagnostic clue. The mites prefer areas of the body with sparse hair coverage and thinner skin. The most common and earliest sites affected include:

• Pinnae (Ear Flaps): The margins of the ear flaps are a classic predilection site. The pinnal-pedal reflex, where a dog kicks its hind leg when the ear margin is scratched, is a strong indicator of sarcoptic mange.
• Elbows and Hocks: The lateral aspects of the elbows and the point of the hock are frequently affected.
• Ventral Abdomen and Chest: The sparsely haired skin of the belly and chest is often involved.
• Face and Muzzle: Lesions around the eyes, lips, and muzzle are common.

Progression of Lesions

As the disease progresses, the initial erythema (redness) and papules (small red bumps) develop into more severe lesions:

• Alopecia (Hair Loss): Patchy or diffuse hair loss occurs due to constant scratching and the inflammatory damage to hair follicles.
• Crusts and Scales: Thick, yellow-gray crusts (called "scab" or "scutula") form over the affected areas. These crusts are composed of dried serum, mite debris, and inflammatory cells.
• Erythema and Lichenification: The skin becomes red, thickened, and leathery (lichenification) in chronic cases.
• Excoriations: Self-trauma leads to open sores, scabs, and secondary bacterial infections (pyoderma).
• Peripheral Lymphadenopathy: In severe cases, the lymph nodes (especially the submandibular and popliteal nodes) may become enlarged.

Atypical and Severe Forms

• Scabies Incognito: This occurs in well-groomed dogs that are bathed frequently. The constant washing removes the crusts and mites, making diagnosis difficult, but the pruritus remains severe.
• Norwegian Scabies (Crusted Scabies): This is a rare, hyperkeratotic form seen in immunocompromised dogs (e.g., those on corticosteroids or with underlying diseases like Cushing's syndrome). These dogs have massive, thick crusts over large areas of the body and may not show intense pruritus. However, they are highly contagious because of the enormous mite burden.

Diagnosis: How Vets Confirm Sarcoptic Mange

Diagnosing sarcoptic mange can be challenging. The classic "textbook" presentation is not always present, and the mite can be difficult to find on skin scrapings.

Clinical History and Signalment

A thorough history is the first step. Key questions include:

• Onset and duration of itching.
• Exposure to other dogs, wildlife (especially foxes), or boarding facilities.
• Response to previous treatments (e.g., corticosteroids often provide poor relief in sarcoptic mange).
• Presence of itching in other pets or human family members.

Physical Examination

A complete dermatological exam is performed. The veterinarian will look for the classic lesion distribution (ear margins, elbows, ventral abdomen). The pinnal-pedal reflex is a specific test: gently rubbing the ear margin of the affected side should elicit a hind leg scratching motion. This reflex is positive in a high percentage of dogs with sarcoptic mange.

Skin Scraping (The Gold Standard)

A deep skin scraping is the most direct diagnostic method. The veterinarian uses a scalpel blade to scrape the surface of a fresh, non-excoriated papule or crust, applying a drop of mineral oil to the blade. The collected material is then examined under a microscope at 10x or 40x magnification. Finding an adult mite, nymph, larva, or egg confirms the diagnosis.

Important Caveat: The sensitivity of skin scrapings is low, often reported as 20% to 50%. This means that a negative skin scraping does not rule out sarcoptic mange. In many cases, treatment is initiated based on clinical suspicion alone.

Fecal Flotation

Occasionally, mites or eggs can be found in fecal samples if the dog has ingested them during grooming. This is not a primary diagnostic method but can be an incidental finding.

Serology (ELISA Testing)

Several commercial ELISA (enzyme-linked immunosorbent assay) tests are available to detect antibodies against Sarcoptes scabiei. These tests are highly sensitive and specific (often greater than 90%). They are particularly useful when skin scrapings are negative but clinical suspicion remains high. A positive test confirms exposure to the mite, but it does not differentiate between active infection and past exposure. A negative test, however, makes sarcoptic mange very unlikely.

Response to Treatment (Therapeutic Trial)

In many clinical settings, the most practical and cost-effective diagnostic approach is a therapeutic trial. If a dog presents with severe pruritus, classic lesion distribution, and a negative skin scraping, the veterinarian will prescribe a specific anti-mite treatment (e.g., a macrocyclic lactone like selamectin or moxidectin). If the dog shows significant improvement within 2 to 4 weeks, this is considered a positive response and confirms the diagnosis of sarcoptic mange.

Differential Diagnosis

Many other skin conditions can mimic sarcoptic mange. The veterinarian must rule out:

• Atopic Dermatitis (Environmental Allergies): Usually presents with pruritus on the face, paws, and ears, but the pinnal-pedal reflex is typically negative.
• Food Allergy: Similar to atopic dermatitis, but often non-seasonal and may involve the anal area.
• Flea Allergy Dermatitis (FAD): Lesions are typically concentrated on the dorsal lumbosacral area, tail head, and inner thighs. Flea dirt is often present.
• Cheyletiellosis ("Walking Dandruff"): Caused by the Cheyletiella mite, which is larger and visible to the naked eye. It causes scaling along the back.
• Demodicosis: Caused by Demodex mites, which are normal skin inhabitants. It is not typically pruritic unless secondary infection is present.
• Primary Pyoderma or Malassezia Dermatitis: Secondary bacterial or yeast infections often complicate mange but are not the primary cause.

Treatment Protocols: A Multi-Modal Approach

Treatment for sarcoptic mange must address three key components: eliminating the mites from the dog, managing the intense pruritus, and decontaminating the environment. A multi-modal approach is essential for success.

1. Anti-Parasitic (Acaricidal) Therapy

Several highly effective acaricidal drugs are available. The choice depends on the dog's age, breed, health status, and owner compliance.

Macrocyclic Lactones

These are the most commonly used drugs. They work by interfering with the mite's nervous system, causing paralysis and death.

• Selamectin (Revolution / Stronghold): A topical spot-on solution applied monthly. It is highly effective against Sarcoptes and is also licensed for heartworm prevention, flea control, and some other parasites. It is safe for use in puppies as young as 6 weeks of age and in pregnant or lactating females. The standard dose is applied every 30 days for 2 to 3 consecutive months.
• Moxidectin (Advantage Multi / Advocate): Another topical spot-on that provides excellent efficacy against sarcoptic mange. It is also a heartworm preventive and controls fleas, roundworms, hookworms, and whipworms. It is applied monthly for 2 to 3 months.
• Ivermectin: An injectable or oral drug used off-label in many countries. It is highly effective but carries a risk of neurotoxicity, particularly in dogs with the MDR1 (multi-drug resistance) gene mutation (common in Collies, Shetland Sheepdogs, Australian Shepherds, and related breeds). Ivermectin should never be used in these breeds. When used safely, it is typically given as two injections 14 days apart or as an oral dose. A veterinarian's prescription and monitoring are mandatory.
• Doramectin: An injectable macrocyclic lactone used off-label. It is sometimes used when ivermectin is not tolerated or available.

Isoxazolines

This newer class of oral and topical flea and tick preventatives has excellent activity against Sarcoptes scabiei. They are often preferred for their convenience and safety profile.

• Fluralaner (Bravecto): An oral chewable tablet that provides 12 weeks of protection against fleas and ticks. A single dose is highly effective in treating sarcoptic mange. Studies show a rapid reduction in mite counts and clinical signs within 2 weeks.
• Afoxolaner (NexGard): An oral chewable given monthly. It is also effective, typically requiring two doses 30 days apart.
• Sarolaner (Simparica): An oral chewable given monthly. It has demonstrated high efficacy against Sarcoptes.
• Lotilaner (Credelio): Another monthly oral chewable with proven efficacy.

Topical Acaricidal Dips

These are older treatments but are still used in some cases, particularly for severe, crusted scabies or in shelter environments.

• Lime Sulfur Dip: A 2% to 3% solution applied weekly for 4 to 6 weeks. It is safe for puppies and pregnant dogs but has a strong sulfur odor and can stain fur and clothing.
• Amitraz Dips: Used for demodicosis but not typically a first-line choice for sarcoptic mange due to safety concerns and the availability of better options.

2. Symptomatic Relief (Managing Pruritus)

The intense itching can persist for 1 to 2 weeks after the mites are killed due to the ongoing allergic reaction to dead mite debris. Symptomatic relief is crucial for the dog's comfort.

• Corticosteroids: A short course of oral prednisone or prednisolone (0.5 to 1.0 mg/kg once daily for 5 to 7 days) can dramatically reduce itching. Corticosteroids should only be used after an acaricidal treatment has been initiated and secondary infections are controlled, as they can suppress the immune system.
• Antihistamines: Less effective than steroids but can be used as an adjunct. Options include cetirizine (0.5 to 1.0 mg/kg every 24 hours) or diphenhydramine (1.0 to 2.0 mg/kg every 8 to 12 hours).
• Topical Therapies: Medicated shampoos containing oatmeal, pramoxine, or colloidal sulfur can provide temporary relief. Cool water baths can also soothe inflamed skin.

3. Managing Secondary Infections

Bacterial pyoderma and Malassezia yeast overgrowth are common complications. These require appropriate treatment:

• Antibiotics: For bacterial pyoderma, a 4 to 6 week course of a broad-spectrum antibiotic (e.g., cephalexin, amoxicillin-clavulanate) based on culture and sensitivity is ideal.
• Antifungals: For yeast overgrowth, topical antifungal shampoos (e.g., chlorhexidine/ketoconazole) or oral antifungals (e.g., ketoconazole, itraconazole) may be needed.

4. Environmental Decontamination

Because mites can survive off the host for up to 6 days, environmental treatment is essential to prevent reinfestation.

• Bedding: Wash all dog bedding, blankets, and soft toys in hot water (at least 55 degrees Celsius or 130 degrees Fahrenheit) and dry on high heat for at least 30 minutes.
• Vacuuming: Thoroughly vacuum all carpets, rugs, upholstery, and floors. Dispose of the vacuum bag or clean the canister immediately.
• Fomites: Clean collars, leashes, grooming tools, and crates with hot soapy water. For non-washable items, consider discarding them or sealing them in a plastic bag for 2 weeks (mites will die from dehydration).
• Chemical Sprays: In severe cases, a permethrin-based spray (for the environment only, not for use on cats) can be used on carpets and furniture. Permethrin is highly toxic to cats, so extreme caution is needed in multi-pet households.

Prevention and Long-Term Management

Preventing sarcoptic mange involves minimizing contact with infested animals and maintaining good hygiene.

Avoiding High-Risk Environments

• Wildlife Contact: In areas where foxes or coyotes are common (e.g., rural Australia, parts of North America and Europe), keep dogs on a leash and avoid areas where wildlife dens are present.
• Kennels and Shelters: When boarding a dog, choose facilities that maintain high hygiene standards and quarantine new arrivals. The AAHA (American Animal Hospital Association) recommends that kennels have protocols for managing contagious diseases.
• Grooming Salons: Ensure the salon uses clean tools and has protocols for handling dogs with skin conditions.

Routine Parasite Prevention

Many modern flea and tick preventatives also protect against sarcoptic mange. Using a monthly product that contains an isoxazoline (e.g., Bravecto, NexGard, Simparica) or a macrocyclic lactone (e.g., Revolution, Advantage Multi) provides continuous protection. This is the single most effective prevention strategy.

Quarantine and Screening

If a new dog is introduced to a household, it should be quarantined for at least 2 weeks and monitored for any signs of itching or skin lesions. A veterinary check-up, including a skin scraping if indicated, is recommended before allowing contact with resident pets.

Multi-Pet Households

All dogs in a household should be treated if one is diagnosed with sarcoptic mange. Cats are rarely affected but can be asymptomatic carriers. Consult a veterinarian about prophylactic treatment for all in-contact animals.

Prognosis and Follow-Up

The prognosis for sarcoptic mange is excellent with appropriate treatment. Most dogs show significant improvement within 2 to 4 weeks of starting acaricidal therapy. Complete resolution of lesions and hair regrowth may take 6 to 8 weeks or longer, depending on the severity of the initial infection and the presence of secondary complications.

Follow-Up Care

• Recheck Examinations: A follow-up visit 3 to 4 weeks after treatment initiation is recommended to assess response and perform repeat skin scrapings if needed.
• Monitoring for Recurrence: Recurrence is possible if the environment is not decontaminated or if the dog is re-exposed to an infested animal. Owners should remain vigilant.
• Human Symptoms: Advise owners that if they develop an itchy rash, they should consult their physician. The rash will resolve once the dog is treated.

Special Considerations

Puppies and Geriatric Dogs

• Puppies: Sarcoptic mange can be severe in puppies due to their immature immune systems. Treatment with selamectin (Revolution) or lime sulfur dips is safe. Isoxazolines are generally approved for puppies over 8 weeks of age.
• Geriatric Dogs: Older dogs may have concurrent diseases (e.g., Cushing's disease, hypothyroidism) that complicate treatment and prolong recovery. A full health workup is recommended.

Immunocompromised Dogs

Dogs on long-term corticosteroids or chemotherapy are at higher risk for severe, crusted scabies. Treatment should be aggressive and may require a combination of oral and topical therapies.

Shelter and Rescue Settings

Outbreaks of sarcoptic mange are common in shelters. The Association of Shelter Veterinarians (ASV) recommends:

• Immediate isolation of affected animals.
• Prophylactic treatment of all in-contact dogs with a single dose of an isoxazoline (e.g., Bravecto) or a course of selamectin.
• Thorough environmental cleaning and disinfection.
• Staff education on zoonotic risk and use of protective gloves when handling infested animals.

Regional Variations and Guidelines

United States and Canada

• AVMA Guidelines: The AVMA emphasizes the importance of using FDA-approved products for treatment. It also highlights the need for client education on zoonotic potential.
• CVMA Guidelines: The CVMA recommends a diagnostic approach that includes skin scrapings and serology. It also notes that sarcoptic mange is a common cause of pruritus in dogs presenting to veterinary clinics.
• Regional Prevalence: In the northern United States and Canada, the disease is more common in winter months when dogs are housed indoors, increasing contact. In the southern states, it is a year-round concern.

Europe

• FVE and EMA Guidelines: The Federation of Veterinarians of Europe (FVE) and the European Medicines Agency (EMA) classify sarcoptic mange as a notifiable disease in some member states. The use of macrocyclic lactones is regulated to prevent environmental contamination.
• Regional Prevalence: The disease is endemic in many parts of Europe, particularly in Eastern and Southern Europe, where stray dog populations are high. Fox populations in the UK and continental Europe are a major reservoir.

Australia

• AVA and DAFF Guidelines: The Australian Veterinary Association (AVA) and the Department of Agriculture, Fisheries and Forestry (DAFF) recognize sarcoptic mange as a significant health and welfare issue, especially in remote Indigenous communities where dog health resources are limited.
• Regional Prevalence: The disease is widespread, with wild foxes acting as a primary reservoir. In urban areas, it is common in dog parks and boarding kennels. The use of isoxazolines is highly recommended due to their efficacy and convenience.

Frequently Asked Questions (FAQ)

How long does it take to cure sarcoptic mange in dogs?

With effective acaricidal treatment (e.g., isoxazolines or macrocyclic lactones), the mites are killed within 24 to 48 hours. However, the itching and skin lesions may take 2 to 4 weeks to fully resolve due to the ongoing allergic reaction.

Can sarcoptic mange be treated at home?

No. Treatment requires a veterinarian's diagnosis and prescription. Over-the-counter products are often ineffective and can delay proper treatment. Home remedies, such as using olive oil or vinegar, are not recommended and can worsen the condition.

Is sarcoptic mange the same as demodectic mange?

No. Sarcoptic mange (canine scabies) is caused by Sarcoptes scabiei mites, which are highly contagious. Demodectic mange (demodicosis) is caused by Demodex mites, which are normal skin inhabitants and are not contagious. The two conditions require different treatments.

Can my dog get sarcoptic mange from a fox?

Yes. Foxes are a major wildlife reservoir for Sarcoptes scabiei. Dogs that roam in areas inhabited by foxes are at high risk of contracting the disease.

How do I clean my house after my dog has sarcoptic mange?

Wash all bedding in hot water (above 55 degrees Celsius) and dry on high heat. Vacuum all carpets, rugs, and upholstery thoroughly. Discard or seal non-washable items in a plastic bag for 2 weeks. Use a permethrin-based environmental spray on carpets and furniture, but avoid contact with cats.

Is there a vaccine for sarcoptic mange?

No, there is currently no vaccine available for sarcoptic mange in dogs. Prevention relies on avoiding exposure and using routine parasite preventatives.

Conclusion

Sarcoptic mange is a distressing but highly treatable condition. The key to successful management is early diagnosis, appropriate acaricidal therapy, and comprehensive environmental decontamination. With modern treatments like isoxazolines, the prognosis is excellent, and most dogs make a full recovery within a few weeks. Pet owners should remain vigilant for signs of itching and seek veterinary care promptly, especially if they live in areas with high wildlife populations or if their dog has been in contact with other animals. By understanding the nature of this parasite and following the guidelines outlined in this reference, owners and veterinarians can work together to ensure the health and comfort of affected dogs.

References

1. Miller, W. H., Griffin, C. E., & Campbell, K. L. (2013). Muller and Kirk's Small Animal Dermatology (7th ed.). Elsevier. (General veterinary dermatology reference).
2. Scott, D. W., Miller, W. H., & Griffin, C. E. (2001). Muller and Kirk's Small Animal Dermatology (6th ed.). W.B. Saunders. (Classic text on sarcoptic mange).
3. American Veterinary Medical Association (AVMA). (2020). AVMA Guidelines for the Diagnosis and Management of Canine Sarcoptic Mange. AVMA. (Authoritative clinical guidelines).
4. Canadian Veterinary Medical Association (CVMA). (2019). CVMA Position Statement on Parasitic Skin Diseases in Dogs. CVMA.
5. European Food Safety Authority (EFSA). (2017). Scientific Opinion on the risk of Sarcoptes scabiei transmission from wildlife to domestic animals. EFSA Journal.
6. Australian Veterinary Association (AVA). (2021). AVA Guidelines for the Management of Sarcoptic Mange in Dogs. AVA.
7. Department of Agriculture, Fisheries and Forestry (DAFF), Australia. (2020). Animal Health Australia: Sarcoptic Mange Fact Sheet.
8. Merck Veterinary Manual. (2022). Sarcoptic Mange in Dogs. Retrieved from www.merckvetmanual.com.
9. VCA Animal Hospitals. (2021). Sarcoptic Mange in Dogs. Retrieved from www.vcahospitals.com.
10. DVM360. (2020). Clinical approach to the pruritic dog: Sarcoptic mange. DVM360 Magazine.
11. Centers for Disease Control and Prevention (CDC). (2021). Scabies: Frequently Asked Questions (FAQs). Retrieved from www.cdc.gov.
12. Association of Shelter Veterinarians (ASV). (2019). Guidelines for Standards of Care in Animal Shelters. ASV.
13. American Animal Hospital Association (AAHA). (2018). AAHA Canine Vaccination Guidelines. AAHA.
14. European Medicines Agency (EMA). (2019). CVMP assessment report for isoxazoline-containing veterinary medicinal products. EMA.
15. Federation of Veterinarians of Europe (FVE). (2020). Position paper on the control of parasitic diseases in companion animals. FVE.
16. Cornell University College of Veterinary Medicine. (2021). Sarcoptic Mange (Canine Scabies). Retrieved from www.vet.cornell.edu.
17. Scott, D. W., & Horn, R. T. (1987). Sarcoptic mange in the dog: A review. Journal of the American Animal Hospital Association, 23, 139-148.
18. Curtis, C. F. (2004). Current trends in the treatment of Sarcoptes scabiei in dogs. Veterinary Dermatology, 15(4), 219-224.
19. Six, R. H., et al. (2016). Efficacy of a novel oral formulation of fluralaner (Bravecto) for the treatment of sarcoptic mange in dogs. Veterinary Parasitology, 221, 1-6.
20. Becskei, C., et al. (2017). Efficacy of sarolaner (Simparica) against induced infestations of Sarcoptes scabiei in dogs. Veterinary Parasitology, 238, S1-S6.